Networks of Centres of Excellence of Canada
Government of Canada

Common menu bar links

Accelerating access to clinical trials for precision cancer therapies

The Networks of Centres of Excellence (NCE) is pleased to announce its renewed support of $18 million over five years, to Exactis Innovation (Exactis).

Renewed funding for Exactis was awarded through the Business-Led Networks of Centres of Excellence (BL-NCE) program. The BL-NCE program funds large-scale collaborative research networks that bring a wide range of research expertise to bear on specific challenges identified by an industrial sector. Budget 2018 announced the consolidation of the Centres of Excellence for Commercialization and Research (CECR) and the BL-NCE programs with the Strategic Innovation Fund (SIF). During this transition, Exactis will continue to receive its funding through the BL-NCE program.

About Exactis

$18 million over 5 years

Exactis Innovation (Exactis) is a pan-Canadian, non-profit network that provides accelerated access to clinical trials for precision cancer therapies in areas of high unmet need to patients who have their cancer molecularly profiled. Exactis’ vision is to integrate precision oncology across Canada and enable greater access to leading edge clinical trials for Canadian cancer patients. It attracts innovative clinical trials and match Canadian patients in its network to personalized oncology treatments using state of the art molecular screening platforms. The continuum of expertise and systems that have been brought together across the Exactis network represent a critical and valuable capability for Canadian cancer patients, clinician scientists and the interaction between academia and the bio-pharmaceutical sector to accelerate precision oncology in Canada. Learn more about Exactis.